Clinical Trial Update: Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome? [Phase 4]

View source ↗

Summary

Phase 4 trial on intralipid infusion for antiphospholipid syndrome in pregnancy was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome in Pregnancy

Snippet

Sponsor: Tanta University | Conditions: Antiphospholipid Syndrome in Pregnancy | Phase 4 | Status: WITHDRAWN